| Comparison of the restricted mean survival time with the... |
16 |
| On estimands and the analysis of adverse events in the p... |
12 |
| Treatment effect quantification for time-to-event endpoi... |
11 |
| Response-adaptive designs for binary responses: How to o... |
8 |
| Some statistical considerations in the clinical developm... |
8 |
| Propensity-score-based priors for Bayesian augmented con... |
7 |
| Effect of heteroscedasticity between treatment groups on... |
6 |
| Propensity score matched augmented controls in randomize... |
6 |
| Better decision making in drug development through adopt... |
5 |
| BOIN-ET: Bayesian optimal interval design for dose findi... |
5 |
